Research · 2026 · 17 min read

Major Depressive Disorder Recurrent (F33) - ICD-10 Guide for Clinicians Guide for Mental Health Professionals

A comprehensive ICD-10 guide for mental health professionals on Major Depressive Disorder, Recurrent (F33). Includes diagnostic criteria, coding, assessment tools, and evidence-based treatments.

Research

A comprehensive ICD-10 guide for mental health professionals on Major Depressive Disorder, Recurrent (F33). Includes diagnostic criteria, coding, assessment tools, and evidence-based treatments.

PrecisionMind Team

June 16, 2025

11 min read

Table of contents

Quick Reference

Code : F33 (with 4th and 5th character specifications) Diagnosis : Major Depressive Disorder, Recurrent Category : Mood (Affective) Disorders Billing Status : Active code for reimbursement (requires 4th character) DSM-5 Equivalent : 296.3x (Major Depressive Disorder, Recurrent) Common Comorbidities : Anxiety Disorders, Substance Use Disorders, Personality Disorders, Chronic Pain, Cardiovascular Disease

Clinical Description

Major Depressive Disorder, Recurrent is characterized by two or more major depressive episodes separated by at least 2 months of remission. Each episode involves persistent depressed mood and/or loss of interest or pleasure, accompanied by additional symptoms that cause clinically significant distress or functional impairment.

ICD-10 Coding Specifications

F33.0 - Recurrent depressive disorder, current episode mild F33.1 - Recurrent depressive disorder, current episode moderate F33.2 - Recurrent depressive disorder, current episode severe without psychotic features F33.3 - Recurrent depressive disorder, current episode severe with psychotic features F33.4 - Recurrent depressive disorder, currently in remission F33.8 - Other recurrent depressive disorders F33.9 - Recurrent depressive disorder, unspecified

Diagnostic Criteria

For Major Depressive Episode :

• Five or more of the following symptoms present during the same 2-week period (at least one must be depressed mood or loss of interest/pleasure): Depressed mood most of the day, nearly every day Markedly diminished interest or pleasure in activities Significant weight loss/gain or appetite changes Insomnia or hypersomnia nearly every day Psychomotor agitation or retardation Fatigue or loss of energy nearly every day Feelings of worthlessness or excessive/inappropriate guilt Diminished ability to think/concentrate or indecisiveness Recurrent thoughts of death or suicidal ideation

Five or more of the following symptoms present during the same 2-week period (at least one must be depressed mood or loss of interest/pleasure):

• Depressed mood most of the day, nearly every day

• Markedly diminished interest or pleasure in activities

• Significant weight loss/gain or appetite changes

• Insomnia or hypersomnia nearly every day

• Psychomotor agitation or retardation

• Fatigue or loss of energy nearly every day

• Feelings of worthlessness or excessive/inappropriate guilt

• Diminished ability to think/concentrate or indecisiveness

• Recurrent thoughts of death or suicidal ideation

For Recurrent Specification :

• History of at least one previous major depressive episode

• Current episode meets criteria for major depressive episode

• Episodes separated by at least 2 consecutive months without significant mood symptoms

Severity Specifiers

Severity

Criteria

Functional Impact

Mild

Few symptoms beyond minimum required; minor functional impairment

Able to function with effort

Moderate

Symptoms/functional impairment between mild and severe

Significant functional difficulties

Severe

Most symptoms present; marked functional impairment

Substantial impairment in most areas

With Psychotic Features

Delusions or hallucinations present

Severe impairment with reality testing issues

Differential Diagnosis

Condition

Distinguishing Features

ICD-10 Code

Bipolar I Disorder

History of manic episodes

F31.x

Bipolar II Disorder

History of hypomanic episodes

F31.81

Persistent Depressive Disorder

Chronic depression lasting 2+ years

F34.1

Adjustment Disorder with Depressed Mood

Clear stressor, symptoms within 6 months

F43.21

Substance-Induced Mood Disorder

Temporal relationship with substance use

F10-F19

Medical Condition-Related

Due to physiological effects of medical condition

F06.3x

Bereavement

Normal grief response (though can co-occur). Must not include acute safety risks or persistent decline in function.

Z63.4

Transdiagnostic Considerations

MDD is part of the Internalizing disorders spectrum, sharing common symptoms and treatments with anxiety disorders and trauma-related conditions. Comorbidity rates are high, and treatment approaches often need to address multiple conditions simultaneously.

Assessment Tools

Validated Screening & Assessment Instruments

Instrument

Description

Scoring

PHQ-9

9-item self-report depression screener

0-4: Minimal

5-9: Mild

10-14: Moderate

15-19: Moderately Severe

20-27: Severe

Beck Depression Inventory-II (BDI-II)

21-item self-report measure

0-13: Minimal

14-19: Mild

20-28: Moderate

29-63: Severe

Hamilton Depression Rating Scale (HAM-D)

Clinician-administered, 17 or 21-item scale

0-7: Normal

8-16: Mild

17-23: Moderate

≥24: Severe

Montgomery-Ã sberg Depression Rating Scale (MADRS)

10-item clinician-rated scale

0-6: Normal

7-19: Mild

20-34: Moderate

35-60: Severe

Geriatric Depression Scale (GDS)

15 or 30-item yes/no format for older adults

15-item: 0-4: Normal

5-8: Mild

9-11: Moderate1

2-15: Severe

Edinburgh Postnatal Depression Scale (EPDS)

10-item scale for perinatal depression

Score ≥10 indicates possible depression

Score ≥13 indicates likely depression

Treatment Approaches

Evidence-Based Psychotherapy Options

Psychotherapy is a cornerstone of depression treatment, with multiple approaches showing strong efficacy. The choice of therapy should be individualized based on patient preferences, symptom profile, and treatment history.

Approach

Level of Evidence

Key Components

Typical Duration

Cognitive Behavioral Therapy (CBT)

Strong

Cognitive restructuring, behavioral activation, relapse prevention

16-20 sessions

Interpersonal Therapy (IPT)

Focus on interpersonal relationships, grief, role transitions

12-16 sessions

Behavioral Activation (BA)

Activity scheduling, mood monitoring, values-based action

Psychodynamic Therapy

Insight-oriented, transference work, unconscious patterns

16-30 sessions

Dialectical Behavior Therapy (DBT)

Mindfulness, distress tolerance, emotion regulation

12-24 sessions

Acceptance and Commitment Therapy (ACT)

Psychological flexibility, values clarification, mindfulness

Evidence-Based Medication Options

Antidepressant medications are highly effective for moderate to severe depression. Treatment selection should consider symptom profile, side effect tolerance, drug interactions, and patient preferences.

Medication Class

First-Line Options

Starting Dose

Target Dose

Notes

SSRIs

Sertraline

Escitalopram

Fluoxetine

Citalopram

25-50 mg/day

5-10 mg/day

10-20 mg/day

50-200 mg/day

20-80 mg/day

20-40 mg/day

Generally well-tolerated, sexual side effects common

SNRIs

Venlafaxine XR

Duloxetine

Desvenlafaxine

37.5-75 mg/day

30-60 mg/day

50 mg/day

75-300 mg/day

60-120 mg/day

50-100 mg/day

Monitor blood pressure, discontinuation syndrome

Atypical Antidepressants

Bupropion XL

Mirtazapine

Vortioxetine

150 mg/day

15 mg/day

300-450 mg/day15-45 mg/day10-20 mg/day

Bupropion: seizure risk, weight loss

Mirtazapine: sedation, weight gain

Tricyclics

Nortriptyline

Amitriptyline

25 mg/day

75-150 mg/day75-300 mg/day

Cardiac monitoring, anticholinergic effects

Treatment-Resistant Depression Options

Intervention

Evidence Level

Considerations

Medication Augmentation

Lithium, thyroid hormone, antipsychotics

Combination Therapy

Two antidepressants with different mechanisms

Electroconvulsive Therapy (ECT)

Most effective for severe, psychotic, or catatonic depression

Transcranial Magnetic Stimulation (TMS)

FDA-approved for treatment-resistant depression

Ketamine/Esketamine

Rapid-acting, FDA-approved for treatment-resistant depression

Vagus Nerve Stimulation (VNS)

Emerging

For chronic, treatment-resistant cases

Integrative Treatment Considerations

• Exercise: Moderate aerobic exercise (30+ minutes, 3-5 times/week) shows efficacy comparable to medication

• Sleep interventions: CBT for insomnia, sleep hygiene, addressing sleep disorders

• Nutritional factors: Mediterranean diet, omega-3 fatty acids, vitamin D supplementation

• Light therapy: Particularly effective for seasonal patterns

• Mindfulness-based interventions: MBSR, MBCT for relapse prevention

• Social support: Group therapy, peer support, family involvement

Addressing Common Treatment Challenges

Challenge

Strategies

Medication non-adherence

Psychoeducation, simplified dosing, side effect management

Suicidal ideation

Safety planning, crisis contacts, family involvement

Cognitive symptoms

Cognitive rehabilitation, medication optimization

Chronic pain comorbidity

Integrated pain management, SNRIs, tricyclics

Substance use comorbidity

Integrated treatment, motivational interviewing

Antidepressant resistance

Medication augmentation, combination therapy, ECT

Documentation, Coding, and Reimbursement

ICD-10 Coding Tips

• F33 requires a 4th character to specify current episode severity

• 5th character may be used for additional specifications (e.g., F33.10 for mild episode without somatic syndrome)

• Document episode count and duration of remission periods

• Specify psychotic features when present (F33.3)

• Use F33.4 for patients currently in remission

• Can be used as primary or secondary diagnosis

Medical Necessity Documentation Language

Example statements to support medical necessity:

• "Patient exhibits significant functional impairment in [specific domains] as evidenced by [specific examples]"

• "Current major depressive episode represents [#] recurrence, with previous episodes occurring in [timeframe]"

• "PHQ-9 score of [X] indicates [severity level] depression requiring professional intervention"

• "Patient reports [specific symptoms] occurring daily for [duration] weeks"

• "Suicidal ideation present with [frequency/intensity] requiring immediate intervention"

Specific Payer Considerations

Payer

Typical Reimbursement

Authorization Requirements

Session Limits

Medicare

Covered under Part B

No prior auth for outpatient

No specific limit

Medicaid

Varies by state

Often requires auth after 10-12 sessions

BCBS

Covered

May require auth after 12-16 sessions

Varies by plan

Aetna

Some plans require auth

Often 26 sessions/year

UnitedHealthcare

Client Education Resources

Handouts for Clients

• Understanding Depression: NIMH Information Sheet

• Mood Tracking Log

• Behavioral Activation Worksheet

• Sleep Hygiene for Depression

• Medication Information for Depression

Digital Resources

• Recommended Apps: Moodtools: CBT-based depression management Sanvello: Mood tracking and coping skills Headspace: Meditation and mindfulness Daylio: Mood and activity tracking

Recommended Apps:

• Moodtools: CBT-based depression management

• Sanvello: Mood tracking and coping skills

• Headspace: Meditation and mindfulness

• Daylio: Mood and activity tracking

• Online Communities: NAMI (national precisionmindnce on mental illness) Depression and Bipolar Support PrecisionMindnce (DBSA) online support groups

Online Communities:

• NAMI (national precisionmindnce on mental illness)

• Depression and Bipolar Support PrecisionMindnce (DBSA) online support groups

Psychoeducational Talking Points

• The neurobiological basis of depression : Depression involves changes in brain neurotransmitters (serotonin, norepinephrine, dopamine) and neural circuits, particularly those involved in mood regulation, reward processing, and stress response. These biological changes explain why depression isn't simply "feeling sad" but involves physical symptoms like fatigue, sleep disturbances, and concentration difficulties. Understanding the brain basis helps reduce self-blame and stigma while supporting the rationale for both medication and therapy, as treatments work by helping restore healthy brain function through different but complementary mechanisms.

• The relationship between thoughts, mood, and behavior : Depression creates a negative cycle where pessimistic thoughts fuel depressed mood, which leads to withdrawal and inactivity, which then generates more negative thoughts about being "lazy" or "worthless." This cycle is self-reinforcing because depression affects our ability to think clearly and remember positive experiences. Breaking this cycle requires intervening at multiple points: challenging negative thought patterns, gradually increasing meaningful activities, and improving physical health through sleep, exercise, and nutrition.

• Depression as a treatable medical condition : Depression is a legitimate medical illness with biological, psychological, and social components. Like diabetes or heart disease, it requires proper treatment and management. Recovery is possible with appropriate treatment, though it may take time to find the right combination of approaches. The recurrent nature of depression means that learning long-term management strategies is crucial, similar to managing other chronic conditions.

• The importance of behavioral activation : When depressed, people naturally withdraw from activities, which temporarily reduces stress but ultimately worsens depression by eliminating sources of pleasure, accomplishment, and social connection. Behavioral activation involves gradually re-engaging with meaningful activities, even when motivation is low. Starting with small, achievable tasks helps rebuild confidence and energy. The key is that behavior change often precedes mood improvement, so patients shouldn't wait to "feel better" before becoming active.

• Recognizing early warning signs and relapse prevention : Since depression is often recurrent, learning to identify personal early warning signs is crucial for preventing full episodes. These might include sleep changes, increased irritability, social withdrawal, or negative thinking patterns. Developing a relapse prevention plan includes maintaining healthy routines, staying connected with support systems, continuing beneficial activities, and seeking help promptly when warning signs appear. Many people benefit from "maintenance" therapy sessions to monitor symptoms and maintain coping skills.

Reference Materials and Further Reading

Clinical Practice Guidelines

• American Psychological Association Clinical Practice Guidelines for Depression (2019)

• National Institute for Health and Care Excellence (NICE) Depression Guidelines (2022)

• World Health Organization Depression Fact Sheet

Emerging Research

Precision medicine approaches for depression treatment selection

Chekroud AM, Bondar J, Delgadillo J, et al. The promise of machine learning in predicting treatment outcomes in psychiatry. World Psychiatry. 2021 Jun;20(2):154-170.

Digital therapeutics and smartphone-based interventions

Linardon J, Cuijpers P, Carlbring P, Messer M, Fuller-Tyszkiewicz M. The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials. World Psychiatry. 2019 Oct;18(3):325-336.

Inflammation and depression: novel treatment targets Köhler-Forsberg O, N Lydholm C, Hjorthøj C, et al. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand. 2019 Oct;140(4):266-281.

Personalized neurostimulation approaches Siddiqi SH, Weigand A, Pascual-Leone A, Fox MD. Identification of personalized transcranial magnetic stimulation targets based on subgenual cingulate connectivity: An independent replication. Biol Psychiatry. 2021 Jan 15;89(2):e55-e57.

Specialized Books for Clinicians

"Cognitive Therapy of Depression" by Aaron T. Beck, A. John Rush, Brian F. Shaw, and Gary Emery

This seminal work established the foundation for cognitive therapy of depression and remains the gold standard reference. It provides detailed treatment protocols, case examples, and the theoretical framework for understanding depression from a cognitive perspective. Essential for any clinician using CBT approaches with depressed patients.

"Interpersonal Psychotherapy of Depression: A Brief, Focused, Specific Strategy" by Gerald L. Klerman and Myrna M. Weissman

The definitive guide to IPT, this book provides structured treatment protocols focusing on interpersonal relationships and their role in depression. It offers practical session-by-session guidance and is particularly valuable for clinicians treating depression with relationship and social functioning components.

"Behavioral Activation for Depression: A Clinician's Guide" by Christopher R. Martell, Sona Dimidjian, and Ruth Herman-Dunn

This comprehensive guide presents behavioral activation as a standalone treatment for depression. It provides detailed protocols, case examples, and practical strategies for helping clients re-engage with meaningful activities and break the cycle of depression and withdrawal.

"Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse" by Zindel V. Segal, J. Mark G. Williams, and John D. Teasdale

This book presents MBCT as an evidence-based approach for preventing depressive relapse. It provides detailed protocols combining mindfulness practices with cognitive therapy techniques, particularly valuable for clients with recurrent depression.

Last Updated: June 2025

About This Resource : This comprehensive guide was developed to support mental health professionals in providing evidence-based assessment and treatment for clients with Major Depressive Disorder. While efforts have been made to ensure accuracy, clinicians should refer to current DSM-5 and ICD-10 manuals for official diagnostic criteria and stay informed about evolving best practices.

Keep reading — there's more worth your time

More ideas on workflows, alignment, strategy, and what it actually takes to build teams that stay focused and move forward together.

Founder Blog

Jul 30, 2026

4 minutes

A Brief History of Terrible mental health EHRs

mental health practices have spent years stitching together outdated EHRs, disconnected tools, and manual workarounds. PrecisionMind is rebuilding the foundation with one connected system designed around how mental health care actually works.

Oct 27, 2025

6 min read

How PrecisionMind Is Free (and Why You’re Not the Product)

PrecisionMind is free, and you’re skeptical. So when we say it’s truly free, with no usage limits, we know the next question inevitably is — what’s the catch?

Private Practice

Oct 8, 2025

18 min read

A Therapist's Guide to Getting Credentialed with Insurance

Learn how to get credentialed with insurance payers for your mental health practice. This guide covers NPIs, EINs, CAQH profiles, common payers, application steps, and tips to avoid pitfalls, helping therapists expand their client base and streamline billing.